IncFact
Company Profiles: Revenue, Growth, Competition

Viropharma Revenue, Growth & Competitor Profile

DBA SHIRE VIROPHARMA, INC.
Last updated:

Company Awards

Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Viropharma

Access the complete profile.

Viropharma Fast Facts

RevenueN/A    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325414 Biological Product Manufacturing
Address1200 Morris Dr
Wayne, PA 19087

Note: Revenues for privately held companies are statistical evaluations.


Viropharma's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Viropharma is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.


Trademark Applications

Trademark applications show the products and services that Viropharma is developing and marketing. Viropharma doesn't have any recent trademark applications, indicating Viropharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
SOFGARDLA
pharmaceutical products, namely, budesonide oral suspension (BOS) for eosinophilic esophagitis (EoE)
12/06/2019
VIROPHARMA BIOLOGICS
pharmaceutical preparations, namely, biologics and preparations for the treatment of hereditary disorders and conditions associated with inflammatory processes
01/06/2009

See all trademarks and details in the Full Report.


Market Share of Viropharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Viropharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to Viropharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
RED NUCLEUS ENTERPRISESYardley, PA100 
LUMANITYMorrisville, PA53 
VERANOVAWayne, PA51 
QUOTIENT SCIENCES - PHILADELPHIABoothwyn, PA37 
MARINUS PHARMACEUTICALSWayne, PA26 
RESEARCHHorsham, PA9 


(0.0031 s)



Future Competition: Viropharma's Fastest Growing Competitors

These companies are in the same general field as Viropharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Viropharma Competitors